Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.

Drug Healthc Patient Saf · 2010 · PMC3108700 · PMID 21701617

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Bone loss from the spine during the first year of glucocorticoid therapy may vary between 3% and 10%; since the precision error of measurements is approximately 1%, a loss of more than 3% (the least significant change) is likely to be significant.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.